1662.0000 1.70 (0.10%)
NSE Apr 09, 2026 15:31 PM
Volume: 68,094
 

logo
Caplin Point Laboratories Ltd.
10 Nov 2025, 12:00AM
1662.00
0.10%
ICICI Direct
Firm expansion plans in place- In the US, the company is optically transitioning to B2C model to focus on high margin products. The company is also looking for third party ANDAs (4 already acquired, 5 more to come) as well as outsourcing some in-house products to the CMOs for optimal plant utilisation. This, we believe is a part of larger strategy where the company wants to increase the offerings via front-end and at the same time focusing on margin expansion. The legacy LatAm growth was slower seemingly on account of some saturation in the existing markets and focus...
Caplin Point Laborat.. has an average target of 2327.00 from 2 brokers.
More from Caplin Point Laboratories Ltd.
Recommended